Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Vion prepares more active prodrug of beta-L-FD4C

Jan. 27, 1998

Randomized trial compares interferon alfa-2b + ribavirin to interferon alone for HCV

Jan. 26, 1998

Anti-H. pylori agents from Pfizer

Jan. 23, 1998

Pivotal Zadaxin trial to begin in Japan

Jan. 22, 1998

Combination HCV therapy receives priority classification from FDA

Jan. 21, 1998

Interim Maxamine phase I data reported

Jan. 19, 1998

Vertex researchers report 3-D structure of hepatitis C enzyme

Jan. 19, 1998

Overview of antiviral agents in hepatic disease

Jan. 15, 1998

Novel binding mechanism described for Shin Nippon's H+/K+-ATPase inhibitor

Jan. 12, 1998

New antiulcer agent now available in Japan

Jan. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...